[Zoledronic acid efficacy in Paget's disease of bone: a three-year experience].
Conesa Mateos
Arantxa
A
Rotés Sala
Delfín
D
Almirall Bernabé
Miriam
M
Carbonell Abelló
Jordi
J
D000368:Aged; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010001:Osteitis Deformans / Q000188:drug therapy*; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid